Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trial.

Autor: Mensink FB; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., Los J; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., Oemrawsingh RM; Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands., von Birgelen C; Department of Cardiology, Medisch Spectrum Twente, Enschede, the Netherlands., Ijsselmuiden A; Department of Cardiology, Amphia Hospital, Breda, the Netherlands.; Department of Cardiology, Maastricht University Medical Center, the Netherlands., Meuwissen M; Department of Cardiology, Amphia Hospital, Breda, the Netherlands., Cheng JM; Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.; Department of Cardiology, Amphia Hospital, Breda, the Netherlands., van Wijk DF; Department of Cardiology, Noordwest Ziekenhuisgroep, Locatie Alkmaar, Alkmaar, the Netherlands., Smits PC; Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands., Paradies V; Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands., van der Heijden DJ; Department of Cardiology, Haaglanden Medisch Centrum, Den Haag, the Netherlands., Rai H; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Cardiovascular Research Institute Dublin and Department of Cardiology, Mater Private Network, Dublin, Ireland., Ten Cate TJ; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., Camaro C; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., Damman P; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., van Nunen LX; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., Dimitriu-Leen AC; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., van Wely MH; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., Cetinyurek-Yavuz A; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., Byrne RA; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Cardiovascular Research Institute Dublin and Department of Cardiology, Mater Private Network, Dublin, Ireland., van Royen N; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands., van Geuns RM; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publikováno v: Heliyon [Heliyon] 2024 Sep 18; Vol. 10 (19), pp. e38077. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).